By www.regionalmarketresearch.com
Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Insights And Forecast To 2031 Story
94
$ 4900
Non-Alcoholic Steatohepatitis (NASH) Treatment Report report is categorised based on following features:
1. Global Market Players
2. Geopolitical regions
3. Consumer Insights
4. Technological advancement
5. Historic and Future Analysis of the Market
Allergan Plc (Tobira)
Bristol Myers Squibb
Galmed Pharmaceuticals
Genfit SA
Gilead Sciences, Inc.
Intercept Pharmaceuticals, Inc.
Zydus Cadila